It is suitable for risk-averse investors. These are some of the common questions that occur in the mind of investors when thinking of investing in Mutual Funds through a SIP or Systematic Investment plan. Below is the key information for PGIM India Global Agribusiness Offshore Fund PGIM India Global Agribusiness Offshore Fund Growth Launch Date 14 May 10 NAV (28 Dec 20) ₹35.36 Net Assets (Cr) ₹510 on 30 Nov 20 Category Others - Fund of FundAMC Pramerica Asset Managers Private Limited Rating ☆Risk HighExpense Ratio 0.96Sharpe Ratio 2.27Information Ratio 1.5Alpha Ratio 34.58Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years. Kotak Gold Fund is a Gold - Gold fund was launched on 25 Mar 11. It is a fund with High risk and has given a CAGR/Annualized return of 11.6% since its launch. Policybazaar does not in any form or manner endorse the information so provided on the website and strives to provide factual and unbiased information to customers to assist in making informed insurance choices. The microinsurance plan from LIC for up to 5 years of policy term is listed as under. as on 28 Dec 20 DurationReturns1 Month 5.9% 3 Month 12.2% 6 Month 31.9% 1 Year 66.2% 3 Year 20.4% 5 Year 10.8% 10 Year 15 Year Since launch 21.5% Historical performance (Yearly) on absolute basis YearReturns2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% 2014 49.5% 2013 20.9% 2012 34.8% 2011 -11% 2010 31.9% Fund Manager information for Nippon India Pharma Fund NameSinceTenureSailesh Raj Bhan1 Apr 0515.68 Yr.Data below for Nippon India Pharma Fund as on 30 Nov 20 Equity Sector Allocation SectorValueHealth Care98.97% Asset Allocation Asset ClassValueCash1.03%Equity98.97% Top Securities Holdings / Portfolio NameHoldingValueQuantity Aurobindo Pharma Ltd (Healthcare)Equity, Since 31 Dec 15 | AUROPHARMA10%₹434 Cr5,000,000 ↑ 290,000 Sun Pharmaceuticals Industries Ltd (Healthcare)Equity, Since 31 Oct 09 | SUNPHARMA10%₹409 Cr8,000,976 Divi's Laboratories Ltd (Healthcare)Equity, Since 31 Mar 12 | DIVISLAB10%₹397 Cr1,100,000 ↓ -100,075 Cipla Ltd (Healthcare)Equity, Since 31 May 08 | 5000879%₹373 Cr5,000,000 ↑ 300,000 Lupin Ltd (Healthcare)Equity, Since 31 Aug 08 | 5002579%₹357 Cr4,000,025 ↑ 200,000 Dr Reddy's Laboratories Ltd (Healthcare)Equity, Since 30 Jun 11 | 5001247%₹302 Cr625,000 ↑ 25,000 Cadila Healthcare Ltd (Healthcare)Equity, Since 31 Jan 18 | 5323217%₹270 Cr5,998,982 ↑ 1,250,000 Gland Pharma Ltd (Healthcare)Equity, Since 30 Nov 20 | GLAND6%₹269 Cr1,272,764 ↑ 1,272,764 Thyrocare Technologies Ltd (Healthcare)Equity, Since 31 May 16 | THYROCARE6%₹231 Cr2,103,110 ↓ -220,169 Fortis Healthcare Ltd (Healthcare)Equity, Since 31 Aug 18 | 5328435%₹217 Cr14,403,5417. Return for 2019 was 21.7% , 2018 was 6.6% and 2017 was 2.8% . The fund has offered benchmark historic returns. Below is the key information for SBI Gold Fund SBI Gold Fund Growth Launch Date 12 Sep 11 NAV (29 Dec 20) ₹15.5504 ↓ -0.01   (-0.05 %) Net Assets (Cr) ₹842 on 30 Nov 20 Category Gold - GoldAMC SBI Funds Management Private Limited Rating ☆☆Risk Moderately HighExpense Ratio 0.47Sharpe Ratio 1.33Information Ratio 0Alpha Ratio 0Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years. Return for 2019 was 34.2% , 2018 was 6.5% and 2017 was 18.1% . You can simply start investing as per your goals (short-term or long-term) and attain an increase in wealth after a certain period of time. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 4.9% since its launch. National Pension System. DateValue30 Nov 15₹10,00030 Nov 16₹11,31030 Nov 17₹11,36430 Nov 18₹11,55230 Nov 19₹14,39830 Nov 20₹18,331 SBI Gold Fund SIP Returns  Goal based      Monthly SIPMy Monthly Investment:₹Investment Tenure:YearsExpected Annual Returns:% Total investment amount is ₹300,000 expected amount after 5 Years is ₹426,080. If you are really eager to start investing, one … HDFC Gold Fund To seek capital appreciation by investing in units of HDFC Gold Exchange Traded Fund (HGETF). In my opinion, CIT Bank offers the best CD product. It is a fund with High risk and has given a CAGR/Annualized return of 17.1% since its launch. 1. Return for 2019 was 30.9% , 2018 was 0.3% and 2017 was 11.9% . Below is the key information for Kotak Gold Fund. 1.4 lakhs. It is also one of the best sip plan for 5 years and an investment of Rs. Kotak Gold Fund is a Gold - Gold fund was launched on 25 Mar 11. Best Credit Cards of 2020 Rewards Cards 101 Best Rewards Credit Cards Credit Card Reviews Banking. **Discount is offered by the Insurance company as approved by IRDAI for the product under File & Use guidelines #On the basis of your profile, CIN: U74999HR2014PTC053454 Policybazaar Insurance Brokers Private Limited (formerly known as Policybazaar Insurance Web Aggregator Private Limited) Policybazaar is currently registered as a Web aggregator by IRDAI. Return for 2019 was 1.7% , 2018 was 3.6% and 2017 was 7.6% . In addition to the usual suspects, consider making significant time investments in personal growth to feed your curiosities, educate yourself, and strive to craft your best life. Net Profit of ₹126,080 Invest Now Invest Now Returns for Kotak Gold Fund Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. It is suitable for investors who are looking for short-term capital growth. Micro insurance plans are a perfect mix of insurance, investment and savings. Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana - 122001, IRDAI Web aggregator Registration No. Whether you plan to retire early, late, or never ever, … PGIM India Global Agribusiness Offshore Fund is a Others - Fund of Fund fund was launched on 14 May 10. This is an open-ended debt MF. TATA Digital India Fund The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in Information Technology Sector in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.